| Previous close | 62.50 |
| Open | 62.43 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 62.33 - 62.93 |
| 52-week range | 58.29 - 66.80 |
| Volume | 6,061,224 |
| Avg. volume | 8,347,362 |
| Market cap | 171.49B |
| Beta | 0.96 |
| PE ratio (TTM) | 39.96 |
| EPS (TTM) | 1.57 |
| Earnings date | 27 Oct 2017 |
| Dividend & yield | 1.88 (3.00%) |
| Ex-dividend date | 2017-09-14 |
| 1y target est | 69.95 |
- CNBC•3 hours ago
Valeant Pharmaceuticals CEO: 'It's been a challenging 15 months, but we've made great progress'
Jim Cramer sat down with Joe Papa, the new CEO of the controversial Valeant Pharmaceuticals, to catch up on the drugmaker's turnaround.
- Fortune•4 hours ago
Trump Council CEOs Had Been Pressured to Step Down For Months
Activists have been working behind the scenes since January.
- The Wall Street Journal•5 hours ago
CEO Timeline: Who Quit White House Councils When, And How Trump Reacted
Two of President Donald Trump's business councils unraveled on Wednesday, following a series of defections by chief executives over Mr. Trump's comments about the violence in Charlottesville, Va. Here ...
